Claudia Liesel Gray
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claudia Liesel Gray has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Andre van Niekerk
University of Pretoria
3 shared publications - Ashen Nanan
University of the Witwatersrand
3 shared publications - Charles Feldman
University of the Witwatersrand
3 shared publications - Cornelia M. Lodder
Private Practice
3 shared publications - Eftyhia Vardas
Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
3 shared publications - Guy Antony Richards
University of the Witwatersrand
3 shared publications
Latest Publications
- Open Access
- 9 December 2024
- Published by AOSIS in South African Family Practice
- Vol. 67 (1) , 1
Erratum: Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group
The South African Family Practice is a peer-reviewed scientific journal, which strives to provide primary care physicians (and their teams), as well as researchers, with a broad range of scholarly work in the disciplines of family medicine, primary health care, rural medicine, district health and other related fields. SAFP publishes original research, clinical reviews, and pertinent commentary that advance the knowledge base of these disciplines.
- 9 December 2024
- Published by AOSIS in South African Family Practice
- Vol. 67 (1) , 1
Open AccessErratum: Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group
The South African Family Practice is a peer-reviewed scientific journal, which strives to provide primary care physicians (and their teams), as well as researchers, with a broad range of scholarly work in the disciplines of family medicine, primary health care, rural medicine, district health and other related fields. SAFP publishes original research, clinical reviews, and pertinent commentary that advance the knowledge base of these disciplines.
- 1 November 2023
- Published by Medpharm Publications in South African General Practitioner
- Vol. 4 (4) , 124-136
Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group
BackgroundAllergic rhinitis (AR) has a significant impact on the community as a whole with regard to quality of life and its relationship to allergic multi-morbidities. Appropriate diagnosis, treatment and review of the efficacy of interventions can ...
- 1 November 2023
- Published by Medpharm Publications in South African General Practitioner
- Vol. 4 (4) , 124-136
Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group
BackgroundAllergic rhinitis (AR) has a significant impact on the community as a whole with regard to quality of life and its relationship to allergic multi-morbidities. Appropriate diagnosis, treatment and review of the efficacy of interventions can ...
- Open Access
- 30 October 2023
- Published by AOSIS in South African Family Practice
- Vol. 65 (1) , 11-e11
Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group
The South African Family Practice is a peer-reviewed scientific journal, which strives to provide primary care physicians (and their teams), as well as researchers, with a broad range of scholarly work in the disciplines of family medicine, primary health care, rural medicine, district health and other related fields. SAFP publishes original research, clinical reviews, and pertinent commentary that advance the knowledge base of these disciplines.
- 30 October 2023
- Published by AOSIS in South African Family Practice
- Vol. 65 (1) , 11-e11
Open AccessAllergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group
The South African Family Practice is a peer-reviewed scientific journal, which strives to provide primary care physicians (and their teams), as well as researchers, with a broad range of scholarly work in the disciplines of family medicine, primary health care, rural medicine, district health and other related fields. SAFP publishes original research, clinical reviews, and pertinent commentary that advance the knowledge base of these disciplines.
- 1 August 2020
- Vol. 110 (8) , 751-752
The use of disinfection tunnels or disinfectant spraying of humans as a measure to reduce the spread of the SARS-CoV-2 virus
In endeavouring to mitigate the spread of the SARS-CoV-2 virus, a concerning practice of spraying individuals with disinfectant via so-called 'disinfection tunnels' has come to light. The Allergy Society of South Africa supports the World Health Organization in strongly condemning all human spraying, owing to lack of efficacy and potential dangers, especially to patients with coexisting allergic conditions.
- 1 August 2020
- Vol. 110 (8) , 751-752
The use of disinfection tunnels or disinfectant spraying of humans as a measure to reduce the spread of the SARS-CoV-2 virus
In endeavouring to mitigate the spread of the SARS-CoV-2 virus, a concerning practice of spraying individuals with disinfectant via so-called 'disinfection tunnels' has come to light. The Allergy Society of South Africa supports the World Health Organization in strongly condemning all human spraying, owing to lack of efficacy and potential dangers, especially to patients with coexisting allergic conditions.
- Open Access
- 1 January 2020
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 13, 51-66
Current Controversies and Future Prospects for Peanut Allergy Prevention, Diagnosis and Therapies
Peanut allergy has increased substantially in the past few decades, both in developed and developing countries. Peanut allergy has become a major public health concern, affecting up to 1 in 50 children, with repercussions for school and airline policies. Recent research findings have shown that, contrary to the long-standing teaching of “delayed” introduction of allergens, early introduction of peanut protein is of benefit as an allergy prevention strategy, especially in high-risk cases. Ideal dose, frequency and duration of “proactive” peanut therapy for maximum protection remain to be determined in order for it to become acceptable and practical on a large scale. Logistics around widespread screening of high-risk patients remain complex. The correct diagnosis of peanut allergy is crucial and diagnostic tests have been fine-tuned in the past 2 decades in order to help differentiate true allergy from false-positive sensitization through cross-reactivity. Component-resolved diagnostics have become routinely available, and the use of basophil activation tests has increased, although standardization and availability remain issues. Future tests, including epitope testing and histamine-release assays, promise to be even more specific in ruling out false positives and reducing the need for incremental food challenges. Stringent peanut avoidance and prompt treatment of reactions remain the cornerstone of treatment. The concept of exposing the allergic body to small amounts of peanut protein in a cautious, orderly, escalating fashion in the form of desensitization has been widely applied in the past 10– 15 years, mainly in the research domain, but of late spilling over into every-day practice. However, desensitization does not equate to a cure, and has significant safety concerns and practical ramifications; probably requiring lifelong-controlled peanut ingestion for ongoing protection. Further strategies to enhance the safety and efficacy of immunotherapy are under exploration, many with a non-specific immune-modifying effect. Despite recent advances in peanut allergy, we still need to go back to basics with accurate diagnosis, nutritional counselling, well-organized allergy action plans and accessible emergency kits.
- 1 January 2020
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 13, 51-66
Open AccessCurrent Controversies and Future Prospects for Peanut Allergy Prevention, Diagnosis and Therapies
Peanut allergy has increased substantially in the past few decades, both in developed and developing countries. Peanut allergy has become a major public health concern, affecting up to 1 in 50 children, with repercussions for school and airline policies. Recent research findings have shown that, contrary to the long-standing teaching of “delayed” introduction of allergens, early introduction of peanut protein is of benefit as an allergy prevention strategy, especially in high-risk cases. Ideal dose, frequency and duration of “proactive” peanut therapy for maximum protection remain to be determined in order for it to become acceptable and practical on a large scale. Logistics around widespread screening of high-risk patients remain complex. The correct diagnosis of peanut allergy is crucial and diagnostic tests have been fine-tuned in the past 2 decades in order to help differentiate true allergy from false-positive sensitization through cross-reactivity. Component-resolved diagnostics have become routinely available, and the use of basophil activation tests has increased, although standardization and availability remain issues. Future tests, including epitope testing and histamine-release assays, promise to be even more specific in ruling out false positives and reducing the need for incremental food challenges. Stringent peanut avoidance and prompt treatment of reactions remain the cornerstone of treatment. The concept of exposing the allergic body to small amounts of peanut protein in a cautious, orderly, escalating fashion in the form of desensitization has been widely applied in the past 10– 15 years, mainly in the research domain, but of late spilling over into every-day practice. However, desensitization does not equate to a cure, and has significant safety concerns and practical ramifications; probably requiring lifelong-controlled peanut ingestion for ongoing protection. Further strategies to enhance the safety and efficacy of immunotherapy are under exploration, many with a non-specific immune-modifying effect. Despite recent advances in peanut allergy, we still need to go back to basics with accurate diagnosis, nutritional counselling, well-organized allergy action plans and accessible emergency kits.